JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 30 No. 7 1240-1248
© 1989 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baldas, J.
Right arrow Articles by Ivanov, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baldas, J.
Right arrow Articles by Ivanov, Z.

Use of High Performance Liquid Chromatography for the Structural Identification of Technetium-99m Radiopharmaceuticals at the NCA Level

John Baldas, John Bonnyman and Zlata Ivanov

Australian Radiation Laboratory, Yallambie, Australia

Correspondence: For reprints contact: J. Bonnyman, Australian Radiation Laboratory, Lower Plenty Rd., Yallambie, 3085, Australia.

ABSTRACT

Technetium-99m (99mTc) complexes of dithiooxalate (dto) and maleonitriledithiolate (mnt) were prepared by ligand substitution of 99mTcNCl4, dithionite reduction of 99mTcO4, and ligand jexchange of[99mTc]gluconate (Sn). All complexes were characterized by high performance liquid chromatography (HPLC) on a C18 column using gradient elution with a tetrabutylammonium phosphate buffer (40–85% methanol). By performing HPLC of mixtures of the 99mTc complexes with structurally characterized 99Tc complexes of the ligands, it has been shown that at the no carrier added (NCA) level, 99mTcNCl4 labeling leads to the production of [99mTcN(dto)2]2– and [99mTcN(mnt)2]2–. Dithionite reduction and ligand exchange of 99mTc(Sn)-gluconate lead to the production of [99mTcN(mnt)2]2– and not of [99mTcO(mnt)2] which would be the expected product from the results of studies with 99Tc. The product formed by dithionite reduction in the presence of dto was not identified, but it was clearly not [TcO(dto)2], the product expected from 99Tc studies. Studies in mice showed that the biologic behavior of the 99mTc complexes is altered by the presence of the Tc-nitrido group. HPLC results indicate that caution must be taken when extrapolating results obtained using carrier quantities of Tc to the carrier free situation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1989 by the Society of Nuclear Medicine.